Treatment and prognosis of the severe exacerbation in the chronic obstructive pulmonary disease

Revista Clinica Espanola

Volumn 201, Issue 11, 2001, Pages 658-666

  Anón Elizalde J M ^a   Garcia de Lorenzo y Mateos A ^b   alvarez Sala Walther R ^a   Escuela Gerico M P ^a  

^a HOSPITAL VIRGEN DE LA LUZ   (Spain)

^b Hospital Virgen de la Luz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; HOSPITALIZATION; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BAROTRAUMA; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FLUID THERAPY; INTERMITTENT MANDATORY VENTILATION; NEBULIZATION; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; THORAX DRAINAGE;

HUMANS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

AMINOPHYLLINE; ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; METHYLXANTHINE; ORCIPRENALINE; OXYGEN; PLACEBO; THEOPHYLLINE;

EID: 0035543806     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2565(01)70941-1     Document Type: Review

References (103)

1. Optimal assessment and management of chronic obstructive pulmonary disease (COPD)
2. Estudio epidemiológico de la EPOC en España (IBEREPOC): Prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo
3. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
4. Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica
5. National and International Guidelines for COPD
6. Outcome from respiratory failure
7. Developing guidelines
8. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guideline Group of the Standards of Care Committee of the BTS
9. Emergent assessment and management of acute respiratory failure in COPD
10. Role of infection in chronic bronchitis
11. Bacteriologic findings in the transtracheal aspirate from patients with acute exacerbation of chronic bronchitis
12. Branhamella catarrhalis-an emerging human pathogen
13. Nontypable Haemophilus influenzae: A review of clinical aspects, surface antigens and the human immune response to infection
14. Branhamella catarrhalis respiratory infections
15. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients
16. Branhamella catarrhalis: An organism gaining respect as a pathogen
17. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush
18. Role of infection in chronic bronchitis
19. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary disease
20. Oxygen therapy during acute respiratory failure of chronic obstructive pulmonary disease
21. Oxygen therapy
22. Oxygen-induced hypercarbia in obstructive pulmonary disease
23. Monitoring during mechanical ventilation
24. ß-adrenergic bronchodilatadors
25. Comparison of intravenous and inhaled terbutaline in the treatment of asthma
26. Comparison of intravenous and nebulized salbutamol in initial treatment of severe asthma
27. Comparison of inhaled and intravenous terbutaline in acute severe asthma
28. Intravenous versus nebulized terbutaline in patients with severe acute asthma: A double-blind randomized study
29. Plasma concentrations and side-effects of terbutaline
30. Haemodynamic effects of terbutaline in chronic obstructive airways disease
31. Cost-benefit comparisons of aerosol bonchodilator delivery methods in hospitalized patients
32. Equivalence of continous flow nebulizer and metered-dose inhaler with reservoir bag for the treatment of acute airflow obstruction
33. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD
34. A comparison ot the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD
35. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease
36. Comparison between long-term treatment of chronic bronchitic airway obstruction with ipratropium bromide and metaproterenol
37. Comparison of anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90 day multicenter study
38. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease
39. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room
40. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to agonist therapy
41. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease
42. The use of theophylline in irreversible chronic obstructive pulmonary disease
43. Management of asthma and chronic airflow limitation. Are methylxanthines obsolete?
44. Theophylline:Should we discard an old friend?
45. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial
46. Aminophylline therapy for acute bronchospastic disease in the emergency room
47. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
48. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis
49. Severe exacerbations of COPD patients; The role of pulmonary infections
50. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency
51. Controlled trial of oral prednisone in outpatients with acute COPD exacerbations
52. A randomized controlled trial of methylprednisolone in the emergency treatment of acute exacerbations of COPD
53. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
54. Ventilación mecánica, concepto y fundamentos básicos. Reseña histórica y perspectivas futuras
55. Mechanical ventilation of the patient with severe chronic obstructive pulmonary disease
56. Noninvasive positive-pressure ventilation in patients with acute respiratory failure
57. Ventilation of patients with asthma and obstructive lung disease
58. Proportional assist ventilation, a new approach to ventilatory support
59. Complications of mechanical ventilation
60. Noninvasive ventilation
61. Severe exacerbations of chronic obstructive pulmonary disease treated with BiPAP by nasal mask
62. Noninvasive positive pressure ventilation via face mask: First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure
63. Feasibility study of the use of bilevel positive airway pressure for respiratory support in the emergency department
64. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask
65. Noninvasive mechanical ventilation improves the immediate and long-term outcome of COPD patients with acute respiratory failure
66. Noninvasive mechanical ventilation in severe chronic obstructive lung disease and acute respiratory failure: Short and long-term prognosis
67. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease
68. Randomized prospective trial of noninvasive positive pressure ventilation in acute respiratory failure
69. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
70. Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure
71. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: A meta-analysis
72. Cost-effectiveness of noninvasive ventilation for acute chronic obstructive pulmonary disease: Cashing in too quickly
73. Recommendations for the management of COPD
74. Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation: A reevaluation
75. Conservative treatment of acute respiratory failure in patients with chronic obstructive lung disease
76. Mechanical ventilation in medical and neurological diseases: 11 years of experience
77. Conservative and respirator treatment of acute insufficiency in patients with chronic obstructive lung disease: A reappraisal
78. Acute respiratory failure in chronic obstructive pulmonary disease: Immediate and long-term prognosis
79. The management of respiratory failure in chronic obstructive lung disease
80. Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: A reappraisal
81. Mechanical ventilation for pulmonary disease
82. Clinical outcome of respiratory failure in patients requiring prolonged (> 24 hours) mechanical ventilation
83. Outcome and function following prolonged mechanical ventilation
84. Failure to predict 6-month survival of patients with COPD requiring mechanical ventilation by analysis of simple indices
85. Determinants of weaning and survival among patients with COPD who require mechanical ventilation for acute respiratory failure
86. Long-term survival of patients with chronic obstructive pulmonary disease following mechanical ventilation
87. Severe COPD and acute respiratory failure. Correlates for survival at the time of tracheal intubation
88. Survival and prediction of succesful ventilator weaning in COPD patients requiring mechanical ventilation for more than 21 days
89. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease
90. Mechanical ventilation of patients on long-term oxygen therapy with acute exacerbations of chronic obstructive pulmonary disease: Prognosis and cost-utility analysis
91. Survival data in patients with acute and chronic lung disease requiring mechanical ventilation
92. Treatment of acute respiratory acidosis in chronic obstructive lung disease
93. Respiratory failure revisited: Acute exacerbations of chronic bronchitis between 1961-68 and 1970-76
94. Outcomes following acute exacerbation of severe chronic obstructive lung disease
95. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease
96. Determinants of immediate survival among chronic respiratory insufficiency patients admitted to an intensive care unit for acute respiratory failure
97. Oxigenoterapia contínua domiciliaria. Estudio de 344 pacientes
98. Predictors for early mortality in patients with long-term oxygen therapy
99. Twelve year clinical study of patients with hypoxic cor pulmonale given long-term domiciliary oxygen therapy
100. Survival of patients with chronic obstructive pulmonary disease receiving long-term domiciliary oxygen therapy
101. Prognosis of severely hypoxemic patients receiving long term oxygen therapy
102. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure
103. Non invasive positive pressure ventilation in acute respiratory failure